Mary Dooley
Net worth: 8 666 $ as of 31/05/2026
Net worth: 8 666 $ as of 31/05/2026
Mary Beth Dooley is currently Chief Executive & Financial Officer at Synlogic, Inc., a position starting in 2025.
Formerly, Ms. Dooley was Senior Manager-Financial Planning Analysis at Idera Pharmaceuticals, Inc. from 2014 to 2018 and Assistant Vice President at Boston Private Bank & Trust Co. from 2005 to 2011.
Education includes undergraduate studies at Bates College and graduate studies including an MBA at Northeastern University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SYNLOGIC INC 0.11% | 31/03/2026 | 12,744 ( 0.11% ) | 8 666 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SYNLOGIC, INC. | Chief Executive Officer | 01/01/2025 |
| Companies | Position | End |
|---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | 01/05/2018 |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Corporate Officer/Principal | 01/05/2011 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Finance |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions